glp 1 analogue GLP-1 and Anesthesia: Considerations and Cautions for CRNAs GLP-1-based therapies for diabetes, obesity
Description
Many people start treatment because they want the scale
10.1210/jcem.86.3.7330 15
ETD 12.4%
Not only do I love supporting people on their weight loss journeys, but Ive been on one myself and have experienced these medications firsthand
A possible explanation for the similar effects on weight of both GIP agonism and antagonism is the potential desensitisation of GIP receptors by GIP agonists exposure [57]
